What is bemotrizinol and why is the FDA approval significant?

Bemotrizinol is the first new active sunscreen ingredient approved by the FDA in over 25 years. It provides broad-spectrum UVA and UVB protection, has been used safely in Europe, Asia, and Australia for two decades, and gives U.S. formulators a well-studied option with an excellent safety profile.

How is bemotrizinol different from existing sunscreen ingredients?

Bemotrizinol is highly photostable, meaning it does not break down in sunlight like older filters such as avobenzone. It has minimal skin absorption, very low risk of irritation, and no estrogenic effects—making it one of the most rigorously studied sunscreen filters available.

Will sunscreens with bemotrizinol feel better to wear?

Yes. Because bemotrizinol is a powerful broad-spectrum filter, formulators can use fewer total ingredients at lower concentrations, resulting in lighter, more cosmetically elegant products. Sunscreen only works when people apply it, so improving texture is a real win for skin cancer prevention and healthy aging.

Is bemotrizinol safe for all ages?

The FDA considers bemotrizinol generally recognized as safe and effective for adults and children 6 months of age and older, at concentrations up to 6%. Its safety is backed by more than two decades of real-world use across multiple countries.

When will I be able to buy sunscreens with bemotrizinol?

The FDA issued its final approval order in June 2026. Manufacturers may now incorporate bemotrizinol—sold under the ingredient name Parsol Shield—into OTC sunscreen products. Look for 'bemotrizinol' in the active ingredients list on future product labels.

What sunscreen should I use right now?

Choose a broad-spectrum SPF 30 or higher, apply generously, and reapply every two hours when outdoors. Existing sunscreens are effective—the best sunscreen is always the one you will use consistently.

Why wasn't bemotrizinol available in the U.S. sooner?

Despite EU approval since 2000, U.S. regulatory pathways for new sunscreen ingredients were not updated for decades. The passage of the SAFE Sunscreen Act of 2025 and support from the MAHA Strategy Report helped the FDA finalize its review within seven months of the proposed order.